CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF - Patent 2648736

(19)

(11)

EP 2 648 736 A2

(12)

(43)	Date of publication:
	16.10.2013 Bulletin 2013/42

(21)	Application number: 11846884.2

(22)	Date of filing: 08.12.2011

(51)

International Patent Classification (IPC):

A61K 31/55^(2006.01)

A61K 31/45^(2006.01)

(86)	International application number:
	PCT/US2011/063943

(87)	International publication number:
	WO 2012/078867 (14.06.2012 Gazette 2012/24)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

08.12.2010 US 420899 P

(71)	Applicant: Lycera Corporation
	Ann Arbor, MI 48109 (US)

(72)	Inventors:
	HURD, Alexander, R. Ann Arbor, MI 48103 (US) TAYLOR, Clarke, B. Ann Arbor, MI 48105 (US) TOOGOOD, Peter, L. Ann Arbor, MI 48108 (US) VANHUIS, Chad, A. Hartland, MI 48353 (US)

(74)	Representative: Kirkham, Nicholas Andrew et al
	Graham Watt & Co. LLP St. Botolph's House 7-9 St. Botolph's Road Sevenoaks Kent TN13 3AJ Sevenoaks Kent TN13 3AJ (GB)

(54)	CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF